Veracyte | VCYT - Umsatzerlöse

Aktienkurs
31.09
Täglich Wechseln
-0.26 -0.83%
Monatlich
-4.22%
Jährlich
-2.23%
Q2 Prognose
30.24




Der Umsatz Veränderung Datum
Agenus USD 34.2M 3.97M 2025-12
Agilent USD 1.8B 63M 2025-12
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Bruker USD 977.2M 116.7M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Illumina USD 1.16B 80M 2025-12
Intrexon USD 717K 511K 2024-06
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Laboratory Of America USD 3.52B 40M 2025-12
Ligand Pharmaceuticals USD 59.66M 55.8M 2025-12
Myriad Genetics USD 209.8M 4.1M 2025-12
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Siemens EUR 19.14B 2.29B 2025-12
Sonic Healthcare AUD 5.45B 470M 2025-12
Thermo Fisher Scientific USD 12.21B 1.09B 2025-12
Veracyte USD 140.6M 8.7M 2025-12
Waters USD 932M 132M 2025-12